About US
Contact us
-
Consort to develop delivery device for opioid overdose drugUK-based Consort Medical has signed a contract to develop a new drug delivery device for US-based Opiant Pharmaceuticals’ OPNT003 therapeutic intended to treat an opioid overdose. The partners will w2018/9/12
-
Federal court invalidates Acorda’s patents covering MS drug AmpyraThe US Court of Appeals for the Federal Circuit has invalidated four patents held by biopharmaceutical company Acorda Therapeutics covering multiple sclerosis drug Ampyra (dalfampridine). The ruling2018/9/12
-
Study links common arthritis drug azathioprine to skin cancerA joint study by UK universities has revealed a correlation between commonly used arthritis drug azathioprine and the development of skin cancer. The research was conducted by the University of Dunde2018/9/11
-
Pfizer and Merck drug therapy improves PFS in kidney cancer patientsPfizer and Merck reported positive top-line results from the Phase III JAVELIN Renal 101 clinical trial conducted to assess the cominbation of Bavencio (avelumab) and Inlyta (axitinib) as initial ther2018/9/11
-
Chi-Med’s fruquintinib gets approval for colorectal cancer in ChinaHutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of fruquintinib capsules to treat metastatic colorectal cancer (CR2018/9/10
-
Teva returns laquinimod global rights to Active BiotechTeva Pharmaceutical Industries has returned global development and commercialisation rights to drug candidate laquinimod to Swedish biotechnology company Active Biotech. The move follows Teva’s decis2018/9/10
-
AstraZeneca-backed studies reveal constant risk of CV events and deathFindings from three real-world evidence clinical studies supported by AstraZeneca have indicated the need for better secondary prevention of long-term ischemic risk in people who have survived a heart2018/9/7
-
DuPont Nutrition & Health to Showcase YO-MIX® M11 at the Food Ingredients Asia 2018DuPont will also Share Findings from Recent Consumer Study,Which Demonstrates the Rising Demand for Nutritional Snacks in Southeast Asian Markets JAKARTA, Indonesia, September 5, 2018 –DuPont Nutriti2018/9/7
-
MannKind and United Therapeutics to advance dry powder treprostinilUS-based biopharmaceutical company MannKind has entered an exclusive licensing and collaboration agreement with United Therapeutics over a dry powder formulation of treprostinil. Treprostinil is a va2018/9/6
-
Sanofi agrees on monetary settlement for bribery chargesSanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to allegations of its subsidiaries paying bribes to win contracts. The French p2018/9/6